Unknown receptor overexpressed on target cells

The term "Unknown receptor overexpressed on target cells" is a generic descriptive phrase rather than a specific, characterized biological molecule or therapeutic target. In pharmacological research and drug development, a therapeutic target must be a distinct molecular entity—such as a protein, nucleic acid, or carbohydrate—whose activity can be modified by a drug to achieve a therapeutic effect (Santos et al., 2017, Nature Reviews Drug Discovery). This entry describes a physiological state (overexpression) of an unidentified entity, which is insufficient for structured drug-target interaction analysis. Without a specific molecular identity, it is impossible to determine the target's molecular classification, biological pathways, or role in specific diseases. Furthermore, the lack of a defined structure precludes the identification of interacting drugs, mechanisms of action, or safety profiles. Identifying the specific receptor is a fundamental prerequisite for the development of targeted therapies and clinical biomarkers.

Not applicable